• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.29% Nasdaq Down0.03%

    Sarepta Therapeutics, Inc. (SRPT)

    -NasdaqGS
    26.22 Up 1.96(8.08%) May 22, 4:00PM EDT
    |After Hours : 26.17 Down 0.05 (0.19%) May 22, 7:51PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 9,757   14,219   37,329  
    Cost of Revenue -   -   -  
    Gross Profit 9,757   14,219   37,329  
    Operating Expenses
    Research Development94,231  72,909  52,402  
    Selling General and Administrative49,315  31,594  14,630  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (133,789) (90,284) (29,703)
    Income from Continuing Operations
    Total Other Income/Expenses Net(2,000)(21,701)(91,584)
    Earnings Before Interest And Taxes(135,789)(111,985)(121,287)
    Interest Expense -   -   -  
    Income Before Tax(135,789)(111,985)(121,287)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(135,789)(111,985)(121,287)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (135,789) (111,985) (121,287)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (135,789) (111,985) (121,287)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.